SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing heavy volatility as investors weigh a strong earnings beat and raised guidance against concerns over increased capital expenditures and ongoing profitability challenges. The community remains deeply divided, with bulls pointing to record revenue and AI-driven growth, while bears emphasize GAAP losses and the potential for future share dilution.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense market scrutiny following a massive single-day selloff sparked by earnings-call comments that failed to provide sufficient detail on the company's aggressive investments in robotics, autonomous driving, and AI. The community is sharply divided, with bearish investors warning of further downside toward key technical support levels, while bullish retail traders are actively debating whether to buy the dip in anticipation of a potential short squeeze or long-term value recovery.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as investors await an FDA advisory committee vote on the potential reclassification of several peptides, a development that could expand the company's addressable market in wellness and compounding. While the community is actively debating the likelihood of approval and the potential for a short squeeze given the stock's high short interest, others are focused on upcoming earnings and long-term ecosystem growth.

Albertsons Cos., Inc. engages in the operation of food and drug retail stores. It offers grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. The company was founded by Joe Albertson on July 21, 1939 and is headquartered in Boise, ID.

Albertsons Companies Inc - Ordinary Shares - Class A

Albertsons Companies is trending following a fiscal Q1 earnings miss and a sharp reduction in full-year guidance, which sent shares to a new 52-week low. The community is actively debating the stock's potential as an undervalued turnaround play, focusing on aggressive restructuring plans, potential acquisition interest, and the stock's oversold technical setup.

American Express Co. engages in the provision of card-issuing, merchant-acquiring, and card network businesses. Its products and services include credit cards, business credit cards, corporate programs, gift cards, savings accounts and CDs, and the American Express App. It operates through the following segments: the United States Consumer Services (USCS), Commercial Services (CS), International Card Services (ICS), Global Merchant and Network Services (GMNS), and Corporate and Other. The USCS segment includes proprietary consumer cards and provides services to United States consumers. The CS segment offers corporate and small business cards and provides services to United States businesses. The ICS segment provides consumers, small businesses, and corporate cards outside the United States. The GMNS segment is involved in operating a global payments network that processes and settles card transactions, acquires merchants, and provides multi-channel marketing programs and capabilities, services and data analytics. The Corporate and Other segment covers corporate functions and certain other businesses and operations. It also operates through the following geographical segments: United States, EMEA, APAC, LACC, and Other. The EMEA segment represents Europe, the Middle East, and Africa. The APAC segment refers to Asia Pacific, Australia, and New Zealand. The LACC segment focuses on Latin America, Canada, and the Caribbean. The Other segment includes net costs which are not directly allocated to specific geographic regions. The company was founded by Henry Wells, William G. Fargo, and John Warren Butterfield on March 28, 1850 and is headquartered in New York, NY.

American Express Co.

American Express shares are experiencing active trading as the market weighs a potential regulatory proposal to cap credit card interest rates against the company's strong brand and premium customer base. Investors are closely monitoring the stock ahead of upcoming quarterly earnings, with community discussions heavily focused on technical chart patterns and speculative option plays.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending as investors grapple with a relentless downtrend, fueling intense debate over whether the company is a deep-value opportunity or a failing enterprise. The community is sharply divided, with many expressing frustration over lack of management communication and negative price action, while others highlight institutional accumulation and strategic hires as signs of a potential long-term rebound.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Gold (B) is experiencing significant market interest driven by a strategic pivot toward copper and the anticipated North American IPO of its mining assets, which investors view as a catalyst to unlock shareholder value. While the broader commodity sector faces volatility from Middle Eastern geopolitical tensions, the community remains intensely focused on Barricks robust free cash flow, ongoing share buyback programs, and the company's long-term potential as a critical player in the AI infrastructure and electrification supply chain.

Select Sector SPDR Trust (The) - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

Technology sector ETFs like XLK are facing downward pressure as investors rotate into value-oriented sectors like Energy and Financials amid concerns over AI monetization and valuation. The community is actively debating whether this represents a healthy consolidation phase for long-term accumulation or a more significant shift in market leadership.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is experiencing heightened volatility and community interest due to escalating geopolitical tensions in the Middle East and concerns over US debt, though traders remain frustrated by the instrument's historical decay and decoupled performance. The community is actively debating the potential for a major market correction as traders weigh these macroeconomic pressures against the persistent resilience of major indices.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart Holdings is trending as investors weigh recent conditional approval for the company's new bank charter against persistent volatility and concerns over macro-economic headwinds. While the community remains deeply polarized between bullish sentiment on long-term growth and frustration over stagnant price action, discussion is currently fixated on potential earnings catalysts and the stock's significant short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2026

Summit Therapeutics Inc. (NASDAQ: SMMT) today reported its financial results for the second quarter and six months ended June 30, 2026 and provided an update on clinical and operational progress. The clinical momentum of ivonescimab continues to build, with two recent key data readouts that...

FDA Accepts RVMD's Filing for Daraxonrasib in Pancreatic Cancer 

Revolution Medicines' FDA filing for daraxonrasib in metastatic pancreatic cancer enters an accelerated review program, bringing its first commercial product closer.

SMMT Shares Updated Ivonescimab Survival Data From NSCLC Study 

Summit announces updated HARMONi overall survival data and partners with Arcus to test ivonescimab in kidney cancer, expanding its late-stage development.

Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer

Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, and Summit Therapeutics Inc. (Nasdaq: SMMT), a biopharmaceutical company...

SMMT Stock Gains After Summit Reports Strong Lung Cancer Survival Results — Investors Await Q2 Earnings

Equity

Summit said it has already shared the latest safety data with the U.S. Food and Drug Administration.


Summit Therapeutics to Host Second Quarter 2026 Financial Results & Operational Progress Call on July 23, 2026

Summit Therapeutics Inc. (Nasdaq: SMMT) will host a conference call to announce its second quarter 2026 financial results and provide an update on operational progress on Thursday, July 23, 2026. The call is scheduled to take place at 4:30 p.m. EDT. The live and archived webcast can be accessed...

Summit to Divest Late-Stage Antibiotic Drug to Biossil in $105M Deal

SMMT divests investigational antibiotic ridinilazole to Biossil for upfront cash, milestone payments and royalties as it sharpens its focus on oncology.

Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc.

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced it has signed an agreement with Toronto-based Biossil, Inc. for the sale of ridinilazole, an investigational Phase III precision antibiotic owned by Summit. Biossil is an artificial intelligence (AI)-native biopharma company focused on...

Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsRecursion Pharmaceuticals leverages an artificial intelligence platform to decode biology and automate the drug discovery process...

The New Cancer Moonshot: Innovative Companies Pursuing Game-Changing Therapies

Cancer treatment is undergoing one of the most significant transformations in modern medical history.

$SMMT Q2 &#39;26 Earnings Results &amp; Recap

Reported GAAP EPS of -$0.28 up 63.16% YoY

Stocktwits

Summit Therapeutics Inc

 Q2 '26 Earnings Results & Recap

Reported GAAP EPS of -$0.28 up 63.16% YoY

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$SMMT Q2 '26 Earnings Results & Recap

Reported GAAP EPS of -$0.28 up 63.16% YoY

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.28	--	--	N/A
Q2 '26	-$0.27	-$0.28	-2.04%	MISSED
Q1 '26	-$0.27	-$0.24	10.85%	BEAT
Q4 '25	-$0.09	-$0.29	-233.67%	MISSED
Q3 '25	-$0.18	-$0.31	-76.36%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

SMMTSummit Therapeutics Inc

Latest Earnings Results: Q2 '26

Historical Earnings

Latest SMMT News